Julie Flynn

Novel 2,3-Dihydro-1,4-Benzoxazines as Potent and Orally Bioavailable Inhibitors of Tumor-Driven Angiogenesis

Daniel S. La, Julie Belzile, James Bready et al. · Journal of Medicinal Chemistry · 2008 · 73 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Naphthamides as Novel and Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Design, Synthesis, and Evaluation

Jean-Christophe Harmange, Matthew M. Weiss, Julie Germain et al. · Journal of Medicinal Chemistry · 2008 · 70 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Optimization of the in Vitro Cardiac Safety of Hydroxamate-Based Histone Deacetylase Inhibitors

Michael D. Shultz, Xueying Cao, Christine Chen et al. · Journal of Medicinal Chemistry · 2011 · 64 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

Evaluation of a Series of Naphthamides as Potent, Orally Active Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitors

Matthew M. Weiss, Jean-Christophe Harmange, Anthony Polverino et al. · Journal of Medicinal Chemistry · 2008 · 34 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16